Stocks and Investing Stocks and Investing
Tue, April 16, 2024

Andrew Fein Maintained (UBX) at Strong Buy with Decreased Target to $8 on, Apr 16th, 2024


Published on 2024-10-28 10:23:58 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Maintained "Unity Biotechnology, Inc." (UBX) at Strong Buy with Decreased Target from $10 to $8 on, Apr 16th, 2024.

Andrew, nor any peers, have made any analyst calls on UBX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources